In 2024, there have been numerous developments in hormone therapy, targeting a range of ailments including breast cancer, prostate cancer, and menopause.

1. Menopause Treatment: Based on the patient’s age, duration since menopause, and cardiovascular risk, hormone replacement therapy (HRT) can be safely used to treat menopause symptoms. According to the revised recommendations, women under 60 or within ten years of the onset of menopause who do not have a substantial cardiovascular risk may benefit from HRT under close observation【15†source】.

2. Prostate Cancer: Relugolix, a novel oral hormone medication, has shown encouraging outcomes in the treatment of prostate cancer. In comparison to conventional medicines, it provides a faster recovery of testosterone levels, which is essential for lowering long-term side effects like cardiovascular risks and loss of bone density.

3. Breast Cancer: Hormone therapies for breast cancer have also advanced.

These advancements emphasize the significance of customized methods in hormone therapy, guaranteeing that medications are tailored to specific patient profiles for optimal safety.